Specialty & biosimilars markets

Specialty
& biosimilar
markets

Specialty and Biosimilar Markets: Clinical and Financial Expertise to Drive Success

Biotech consulting has many unique challenges, as specialty drug spend continues to grow at double-digit rates and payer access is becoming more restricted. The expanding biosimilar market has provided more options for payers to implement restrictions. Movement from the medical to pharmacy channel allows payers a higher level of control in managing pharmaceutical reimbursement strategies. Our team has comprehensive clinical and contracting experience to assist and guide manufacturers and payers with realistic solutions.

• In-depth, compelling use of data
  • Drive formulary access and minimize coverage restrictions
  • Specialty and biosimilar market evaluation, including future competition and off-label use

• Patient access and provider support
  • REMS, HUB, reimbursement strategies will drive pull-through

• Biosimilar market
  • Data analysis and strategies for managed markets programs

• Distribution model decision support
  • Limited distribution, wholesaler models, payer access analysis

• Channel distribution management
  • Medical vs. pharmacy channel strategies